This report discusses a physiologically based pharmacokinetic (PBPK) model designed to simulate how nicotine and cotinine are processed in pregnant women’s bodies. Such models help understand drug metabolism during pregnancy.
By analyzing these processes, researchers can better assess the risks of tobacco use during pregnancy and inform public health strategies to protect maternal and fetal health.